Managers / Q2 2021 · view latest →
ARK Investment Management LLC
CIK 0001697748 · 200 CENTRAL AVENUE, ST. PETERSBURG, FL, 33701 · 212-426-7040
Summary
Ark Investment Management LLC reported $53.7B in U.S.-listed holdings across 286 positions for Q2 2021.
Its largest position, TSLA, represents 6.9% of the portfolio.
Compared with Q1 2021, the fund opened 20 new positions and exited 25.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 80.5% · $43.2B
- Other · 11.1% · $6.0B
- ADR · 7.6% · $4.1B
- ETP · 0.6% · $349M
- GDR · 0.1% · $73M
- Other · 0.0% · $10M
Quarter-over-Quarter Changes full breakdown →
vs Q1 2021 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| COINCoinbase Global Inc | NEW | +5.62M | 5.62M | +$1.4B | $1.4B |
| PATHUiPath Inc | NEW | +11.88M | 11.88M | +$807M | $807M |
| TSPHTuSimple Holdings Inc | NEW | +6.47M | 6.47M | +$461M | $461M |
| OKTAOkta Inc | NEW | +365.9K | 365.9K | +$90M | $90M |
| RXRXRecursion Pharmaceuticals Inc | NEW | +2.38M | 2.38M | +$87M | $87M |
| ETSYEtsy Inc | NEW | +353.4K | 353.4K | +$73M | $73M |
| QSIQuantum-Si Inc | NEW | +4.05M | 4.05M | +$50M | $50M |
| ZYUSDZymergen Inc | NEW | +1.10M | 1.10M | +$44M | $44M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2021
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | TSLATesla Inchistory → | Common Stock | 6.87% | $3.7B | 5.43M |
| 2 | TDOCTeladoc Health Inchistory → | Common Stock | 4.96% | $2.7B | 16.02M |
| 3 | ROKURoku Inchistory → | Common Stock | 4.05% | $2.2B | 4.74M |
| 4 | XYZSquare Inchistory → | Common Stock | 3.65% | $2.0B | 8.04M |
| 5 | SHOPShopify Inchistory → | Common Stock | 3.32% | $1.8B | 1.22M |
| 6 | TWLOTwilio Inchistory → | Common Stock | 2.73% | $1.5B | 3.72M |
| 7 | COINCoinbase Global Inchistory → | Common Stock | 2.65% | $1.4B | 5.62M |
| 8 | ZMZoom Video Communications Inchistory → | Common Stock | 2.64% | $1.4B | 3.67M |
| 9 | EXKExact Sciences Corphistory → | Common Stock | 2.48% | $1.3B | 10.73M |
| 10 | Spotify Technology SA | Common Stock | 2.46% | $1.3B | 4.79M |
| 11 | UUnity Software Inchistory → | Common Stock | 2.41% | $1.3B | 11.81M |
| 12 | CRISPR Therapeutics AG | Common Stock | 2.34% | $1.3B | 7.78M |
| 13 | NTLAIntellia Therapeutics Inchistory → | Common Stock | 2.32% | $1.2B | 7.68M |
| 14 | ZZillow Group Inchistory → | Common Stock | 2.31% | $1.2B | 10.15M |
| 15 | TWTRUSDTwitter Inchistory → | Common Stock | 1.59% | $854M | 12.42M |
| 16 | TXG10X Genomics Inchistory → | Common Stock | 1.57% | $842M | 4.30M |
| 17 | BEAMBeam Therapeutics Inchistory → | Common Stock | 1.55% | $832M | 6.46M |
| 18 | PLTRPalantir Technologies Inchistory → | Common Stock | 1.51% | $809M | 30.68M |
| 19 | PATHUiPath Inchistory → | Common Stock | 1.50% | $807M | 11.88M |
| 20 | DOCUDocuSign Inchistory → | Common Stock | 1.46% | $785M | 2.81M |
| 21 | SESea Ltdhistory → | ADR | 1.45% | $777M | 2.83M |
| 22 | Invitae Corp | Common Stock | 1.34% | $722M | 21.40M |
| 23 | PACBPacific Biosciences of Califorhistory → | Common Stock | 1.33% | $716M | 20.48M |
| 24 | DKNG1USDDraftKings Inchistory → | Common Stock | 1.32% | $711M | 13.63M |
| 25 | TWSTTwist Bioscience Corphistory → | Common Stock | 1.25% | $674M | 5.05M |
| 26 | FATEFate Therapeutics Inchistory → | Common Stock | 1.21% | $649M | 7.48M |
| 27 | IRDMIridium Communications Inchistory → | Common Stock | 1.01% | $544M | 13.59M |
| 28 | Skillz Inc | Common Stock | 0.99% | $534M | 24.60M |
| 29 | JDJD.com Inchistory → | ADR | 0.93% | $501M | 6.27M |
| 30 | IOVAIovance Biotherapeutics Inchistory → | Common Stock | 0.89% | $480M | 18.45M |
| 31 | TSPHTuSimple Holdings Inchistory → | Common Stock | 0.86% | $461M | 6.47M |
| 32 | TCEHYTencent Holdings Ltdhistory → | ADR | 0.84% | $452M | 6.00M |
| 33 | TRMBTrimble Inchistory → | Common Stock | 0.80% | $430M | 5.26M |
| 34 | CDNACareDx Inchistory → | Common Stock | 0.78% | $418M | 4.56M |
| 35 | EDITEditas Medicine Inchistory → | Common Stock | 0.76% | $407M | 7.18M |
| 36 | REGNRegeneron Pharmaceuticals Inchistory → | Common Stock | 0.74% | $398M | 713.0K |
| 37 | 2U Inc | Common Stock | 0.73% | $391M | 9.38M |
| 38 | Novartis AG | Common Stock | 0.72% | $389M | 4.27M |
| 39 | NTDOYNintendo Co Ltdhistory → | ADR | 0.71% | $380M | 5.23M |
| 40 | TERTeradyne Inchistory → | Common Stock | 0.69% | $373M | 2.78M |
| 41 | PDPagerDuty Inchistory → | Common Stock | 0.68% | $366M | 8.59M |
| 42 | VRTXVertex Pharmaceuticals Inchistory → | Common Stock | 0.67% | $358M | 1.77M |
| 43 | ISIIonis Pharmaceuticals Inchistory → | Common Stock | 0.66% | $355M | 8.91M |
| 44 | Berkeley Lights Inc | Common Stock | 0.58% | $309M | 6.90M |
| 45 | PPure Storage Inchistory → | Common Stock | 0.55% | $298M | 15.25M |
| 46 | ACCDUSDAccolade Inchistory → | Common Stock | 0.55% | $294M | 5.42M |
| 47 | GBTCGrayscale Bitcoin Trust BTChistory → | Open-End Fund | 0.53% | $285M | 9.56M |
| 48 | PYPLPayPal Holdings Inchistory → | Common Stock | 0.52% | $281M | 965.6K |
| 49 | PRLBProto Labs Inchistory → | Common Stock | 0.52% | $278M | 3.03M |
| 50 | BEKEKE Holdings Inchistory → | ADR | 0.51% | $277M | 5.80M |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $12.9B | 182 | May 12, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $15.1B | 197 | Feb 11, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $16.8B | 196 | Nov 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $13.6B | 191 | Jul 30, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $10.0B | 196 | May 7, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $12.0B | 183 | Feb 4, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $10.9B | 195 | Oct 31, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $11.3B | 190 | Jul 26, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $14.4B | 230 | Apr 18, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $16.9B | 223 | Jan 17, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $13.1B | 226 | Oct 18, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $15.1B | 222 | Jul 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $14.6B | 221 | Apr 17, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $11.5B | 232 | Jan 24, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $14.3B | 250 | Oct 17, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $16.9B | 354 | Jul 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $24.0B | 353 | Apr 19, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $33.1B | 368 | Jan 28, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $41.6B | 301 | Nov 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $53.7B | 286 | Aug 5, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $50.3B | 290 | May 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $37.6B | 245 | Feb 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $16.9B | 223 | Oct 30, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $9.3B | 213 | Aug 11, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $4.0B | 207 | May 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $4.0B | 218 | Jan 31, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $4.6B | 224 | Nov 12, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $4.0B | 235 | Jul 30, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $3.5B | 199 | May 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $2.5B | 194 | Feb 11, 2019 | RESTATEMENT | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.